The University of Georgia’s Center for Molecular Medicine officially has a new home on Riverbend Road, adjacent to the Complex Carbohydrate Research Center, where researchers will continue their work to uncover the molecular and cellular basis of human disease.
Dedicated Sept. 20, the 43,000-square-foot facility will house up to 10 research groups. The $25 million project was funded by $17 million in state funds and $8 million in non-state funds. All research conducted through the center will have a connection to one or more human diseases, furthering the university’s efforts to combat threats to human health.
“This world-class facility represents an investment in health care solutions that will improve the lives of millions of individuals around the globe,” said UGA President Jere W. Morehead. “It also symbolizes the great partnership between the state of Georgia and its flagship university–a partnership that is helping to solve the grand challenges of our time and to fuel economic development in this state.”
Since its founding in 2012, the center has focused on biomedical research that enhances quality of life in communities around the globe with Stephen Dalton, GRA Eminent Scholar of Molecular Cell Biology, as its founding director. Researchers in the CMM will focus on developing therapies and diagnostics for diseases that currently have no cures, including neurological diseases, cardiovascular disease, and metabolic diseases such as diabetes. The center’s researchers also will concentrate on developing new vaccines.
The new facility will promote interdisciplinary collaborations between CMM researchers and investigators from other research centers across campus, including the Center for Drug Discovery, the Center for Tropical and Emerging Global Diseases, and the Complex Carbohydrate Research Center.